Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Aflatoxin Poisoning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1675 Neoplasms 1204 Carcinoma, Non-Small-Cell Lung 1092 Prostatic Neoplasms 893 Multiple Myeloma 699 Leukemia, Myeloid, Acute 632 Neoplasm Metastasis 592 Colorectal Neoplasms 582 Lung Neoplasms 576 Melanoma 553 Lymphoma 528 Leukemia 483 Lymphoma, Non-Hodgkin 470 Leukemia, Lymphocytic, Chronic, B-Cell 437 Ovarian Neoplasms 437 Pancreatic Neoplasms 417 Precursor Cell Lymphoblastic Leukemia-Lymphoma 400 Recurrence 384 Myelodysplastic Syndromes 345 Carcinoma, Renal Cell 342 Lymphoma, Follicular 340 Head and Neck Neoplasms 322 Brain Neoplasms 317 Glioblastoma 312 Lymphoma, Large B-Cell, Diffuse 304 Hodgkin Disease 278 Carcinoma, Hepatocellular 277 Squamous Cell Carcinoma of Head and Neck 254 Lymphoma, Mantle-Cell 248 Colonic Neoplasms 232

Interventions

sodium calcium aluminosilicate, hydrated 1 Calcium Carbonate 1 ACCS100 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01677195 2016-04-19

RDMEACCS100

Texas Enterosorbents Incorporated

Phase 2 Completed

234 enrolled 7 charts

Aflatoxin Poisoning, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡